Unveiling the Dark Matter of Cancer Signaling: How Custom Nanotech is Redefining ErbB Receptor Dynamics
In the high-stakes world of oncology, the ErbB family of receptors—EGFR, HER2, and HER3—has long been a primary target for...
In the high-stakes world of oncology, the ErbB family of receptors—EGFR, HER2, and HER3—has long been a primary target for...